Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

Table 2

Major outcomes of eradication therapy.

	Eradication rate
	EACM ()	EAC ()	value
Intention-to-treat	88% (88/100)	73% (73/100)	0.007
Per-protocol	95.6% (88/92)	79.3% (73/92)	<0.001
Adverse event	30.4% (28/92)	16.3% (15/92)	0.024
Compliance	100% (92/92)	100% (92/92)	1.000

EACM group: 7-day esomeprazole/amoxicillin/clarithromycin/metronidazole therapy; EAC group: 7-day standard esomeprazole/amoxicillin/clarithromycin/triple therapy.